Article ; Conference proceedings: Lessons from TGN-1412 - the impact on phase I clinical trials.
IDrugs : the investigational drugs journal
2007 Volume 10, Issue 4, Page(s) 230–232
MeSH term(s) | Animals ; Antibodies, Monoclonal/adverse effects ; Antibodies, Monoclonal/toxicity ; Antibodies, Monoclonal, Humanized ; Antineoplastic Agents/adverse effects ; Antineoplastic Agents/toxicity ; Clinical Trials as Topic ; Drug Evaluation, Preclinical ; Drug Industry ; Europe ; Humans ; Macaca fascicularis |
---|---|
Chemical Substances | Antibodies, Monoclonal ; Antibodies, Monoclonal, Humanized ; Antineoplastic Agents ; TGN-1412 monoclonal antibody |
Language | English |
Publishing date | 2007-04 |
Publishing country | England |
Document type | Congresses |
ZDB-ID | 2086568-5 |
ISSN | 2040-3410 ; 1369-7056 |
ISSN (online) | 2040-3410 |
ISSN | 1369-7056 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 6320: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.